Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BXP Boston Properties	$67.05 +3.8%	$64.69	$54.22 ▼ $90.11	$10.62B	1.12	1.28 million shs	586,332 shs
HLN Haleon	$11.23 +0.8%	$10.32	$8.25 ▼ $11.35	$50.59B	0.24	8.26 million shs	11.53 million shs

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BXP Boston Properties	0.00%	-4.72%	-1.84%	-7.49%	+9.00%
HLN Haleon	0.00%	+2.48%	+9.52%	+9.90%	+33.17%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BXP Boston Properties	3.853 of 5 stars	3.2	1.0	2.5	1.8	1.0	2.5	1.9
HLN Haleon	2.4418 of 5 stars	2.3	3.0	2.5	0.0	4.0	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BXP Boston Properties	2.42	Hold	$77.67	15.84% Upside
HLN Haleon	2.60	Moderate Buy	$12.33	9.80% Upside

Current Analyst Ratings Breakdown

Latest HELD, HLN, BXP, and HIK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/27/2025	BXP Boston Properties	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$75.00 ➝ $71.00
5/27/2025	HLN Haleon	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$13.40
5/19/2025	BXP Boston Properties	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $78.00
5/9/2025	HLN Haleon	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$11.25
5/6/2025	HLN Haleon	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
5/5/2025	BXP Boston Properties	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$80.00 ➝ $68.00
4/15/2025	BXP Boston Properties	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$100.00 ➝ $85.00
3/17/2025	BXP Boston Properties	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$78.00
3/14/2025	BXP Boston Properties	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$89.00 ➝ $79.00
3/5/2025	HLN Haleon	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/5/2025	HLN Haleon	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold

(Data available from 5/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BXP Boston Properties	$3.43B	3.09	$7.36 per share	9.11	$50.21 per share	1.34
HLN Haleon	$11.23B	4.50	$0.41 per share	27.07	$4.51 per share	2.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BXP Boston Properties	$14.27M	-$0.02	670.76	9.22	0.91	0.38%	3.90%	1.24%	7/29/2025 (Estimated)
HLN Haleon	$1.30B	$0.39	33.01	22.91	2.82	10.85%	14.76%	7.32%	5/28/2025 (Estimated)

Latest HELD, HLN, BXP, and HIK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/29/2025	Q1 2025	BXP Boston Properties	$1.65	$1.64	-$0.01	$1.64	$833.89 million	$865.22 million
2/27/2025	H2 2024	HLN Haleon	N/A	$0.05	N/A	$0.05	$3.38 billion	$3.54 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BXP Boston Properties	$3.92	5.85%	N/A	N/A	N/A
HLN Haleon	$0.23	2.05%	N/A	58.97%	N/A

Latest HELD, HLN, BXP, and HIK Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/27/2025	HLN Haleon	--	$0.1166	1.6%	4/25/2025	4/25/2025	6/5/2025
3/20/2025	BXP Boston Properties	quarterly	$0.98	5.69%	3/31/2025	3/31/2025	4/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BXP Boston Properties	2.09	5.69	5.51
HLN Haleon	0.44	0.84	0.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BXP Boston Properties	98.72%
HLN Haleon	6.67%

Insider Ownership

Company	Insider Ownership
BXP Boston Properties	1.49%
HLN Haleon	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BXP Boston Properties	780	158.33 million	155.98 million	Optionable
HLN Haleon	25,408	4.51 billion	N/A	Not Optionable

HELD, HLN, BXP, and HIK Headlines

Recent News About These Companies

Waverly Advisors LLC Makes New Investment in Haleon plc (NYSE:HLN)

May 27 at 4:39 AM | marketbeat.com

Haleon plc (NYSE:HLN) Shares Purchased by Vident Advisory LLC

May 27 at 4:31 AM | marketbeat.com

Whitening without the pain: Sensodyne Clinical White gives Canadians a reason to smile

May 26 at 8:19 AM | globenewswire.com

Haleon plc (NYSE:HLN) Shares Bought by Royal Bank of Canada

May 26 at 4:07 AM | marketbeat.com

D. E. Shaw & Co. Inc. Sells 339,059 Shares of Haleon plc (NYSE:HLN)

May 26 at 3:34 AM | marketbeat.com

Haleon (NYSE:HLN) Lowered to Hold Rating by Wall Street Zen

May 24 at 11:11 AM | marketbeat.com

Principal Street Partners LLC Invests $472,000 in Haleon plc (NYSE:HLN)

May 22, 2025 | marketbeat.com

Focus Partners Wealth Purchases 38,651 Shares of Haleon plc (NYSE:HLN)

May 22, 2025 | marketbeat.com

Haleon director acquires company shares

May 21, 2025 | uk.investing.com

Haleon plc (NYSE:HLN) Shares Acquired by Quantinno Capital Management LP

May 20, 2025 | marketbeat.com

OMERS ADMINISTRATION Corp Increases Stake in Haleon plc (NYSE:HLN)

May 20, 2025 | marketbeat.com

Haleon plc (NYSE:HLN) Shares Sold by Jane Street Group LLC

May 19, 2025 | marketbeat.com

Brokerages Set Haleon plc (NYSE:HLN) PT at $11.25

May 19, 2025 | americanbankingnews.com

Point72 Asset Management L.P. Acquires Shares of 4,728,497 Haleon plc (NYSE:HLN)

May 18, 2025 | marketbeat.com

Haleon plc (NYSE:HLN) Receives Consensus Rating of "Moderate Buy" from Brokerages

May 18, 2025 | marketbeat.com

Cresset Asset Management LLC Lowers Stock Position in Haleon plc (NYSE:HLN)

May 17, 2025 | marketbeat.com

Bank of America Corp DE Reduces Position in Haleon plc (NYSE:HLN)

May 16, 2025 | marketbeat.com

Marathon Partners Equity Management LLC Takes Position in Haleon plc (NYSE:HLN)

May 15, 2025 | marketbeat.com

Balyasny Asset Management L.P. Makes New $2.56 Million Investment in Haleon plc (NYSE:HLN)

May 15, 2025 | marketbeat.com

Bestuurder Haleon plc koopt aandelen voor £4,051 per stuk

May 13, 2025 | nl.investing.com

Darśana Nair to lead Haleon Saudi Arabia as Kingdom accelerates health transformation under Vision 2030

May 13, 2025 | zawya.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

HELD, HLN, BXP, and HIK Company Descriptions

Boston Properties NYSE:BXP

$67.05 +2.44 (+3.77%)

As of 02:29 PM Eastern

Boston Properties, Inc. (NYSE: BXP) (BXP or the Company) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by joint ventures, BXP's portfolio totals 53.3 million square feet and 188 properties, including 10 properties under construction/redevelopment. BXP's properties include 167 office properties, 14 retail properties (including two retail properties under construction/redevelopment), six residential properties (including one residential property under construction) and one hotel. BXP is well-known for its inhouse building management expertise and responsiveness to clients' needs. BXP holds a superior track record of developing premium Central Business District (CBD) office buildings, successful mixed-use complexes, suburban office centers and build-to-suit projects for a diverse array of creditworthy clients. BXP actively works to promote its growth and operations in a sustainable and responsible manner. BXP has earned a twelfth consecutive GRESB Green Star recognition and the highest GRESB 5-star Rating. BXP, an S&P 500 company, was founded in 1970 by Mortimer B. Zuckerman and Edward H. Linde and became a public company in 1997.

Haleon NYSE:HLN

$11.22 +0.09 (+0.76%)

As of 02:29 PM Eastern

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time